|
1
|
Banerjee S and Gore M: The future of
targeted therapies in ovarian cancer. Oncologist. 14:706–716. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang B, Wang C, Han Y, Hu X, Zheng L and
Zhao Y: Isolation and identification of minor bioactive saponins
from the leaves of Panax notoginseng. Zhong Yao Cai.
27:489–491. 2004.(In Chinese). PubMed/NCBI
|
|
3
|
Sun H, Yang Z and Ye Y: Structure and
biological activity of protopanaxatriol-type saponins from the
roots of Panax notoginseng. Int Immunopharmacol. 6:14–25.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Popovich DG and Kitts DD:
Structure-function relationship exists for ginsenosides in reducing
cell proliferation and inducing apoptosis in the human leukemia
(THP-1) cell line. Arch Biochem Biophys. 406:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park SC, Yoo HS, Park C, Cho CK, Kim GY,
Kim WJ, Lee YW and Choi YH: Induction of apoptosis in human lung
carcinoma cells by the water extract of Panax notoginseng is
associated with the activation of caspase-3 through downregulation
of Akt. Int J Oncol. 35:121–127. 2009.PubMed/NCBI
|
|
6
|
Popovich DG and Kitts DD: Ginsenosides
20(S)-protopanaxadiol and Rh2 reduce cell proliferation and
increase sub-G1 cells in two cultured intestinal cell lines,
Int-407 and Caco-2. Can J Physiol Pharmacol. 82:183–190. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen G, Yang M, Nong S, Yang X, Ling Y,
Wang D, Wang X and Zhang W: Microbial transformation of
20(S)-protopanaxadiol by Absidia corymbifera. Cytotoxic
activity of the metabolites against human prostate cancer cells.
Fitoterapia. 84:6–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rittling SR and Chambers AF: Role of
osteopontin in tumour progression. Br J Cancer. 90:1877–1881. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tilli TM, Franco VF, Robbs BK, Wanderley
JL, da Silva FR, de Mello KD, Viola JP, Weber GF and Gimba ER:
Osteopontin-c splicing isoform contributes to ovarian cancer
progression. Mol Cancer Res. 9:280–293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei S and Lu XY: Effects of RNA
interference targeting OPN on the in vitro proliferation of human
ovarian cancer cell line HO-8910PM. Acta Acad Med Sinicae XuZhou.
30:504–510. 2010.(In Chinese).
|
|
11
|
Zhang X, Samadi AK, Roby KF, Timmermann B
and Cohen MS: Inhibition of cell growth and induction of apoptosis
in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural
withanolide Withaferin A. Gynecol Oncol. 124:606–612. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao X, Zou J, Bui-Nguyen TM, Bai P, Gao
L, Liu J, Liu S, Xiao J, Chen X, Zhang X and Wang H: Paris saponin
II of Rhizoma raridis- a novel inducer of apoptosis in human
ovarian cancer cells. Biosci Trends. 6:201–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liotta LA, Tryggvason K, Garbisa S, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Comoglio PM and Trusolino L: Invasive
growth: From development to metastasis. J Clin Invest. 109:857–862.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang L and Li Y: Inhibitory effects of
natural food dyes genistein on invasion of SKOV3 human ovarian
carcinoma cells in vivo and in vitro. Adv Mat Res 781–784.
1152–1155. 2013. View Article : Google Scholar
|
|
16
|
Kim JH, Skates SJ, Uede T, Wong KK,
Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW and Mok SC:
Osteopontin as a potential diagnostic biomarker for ovarian cancer.
JAMA. 287:1671–1679. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Wei L, Zhao W, Wang X, Zheng G,
Zheng M, Song X and Zuo W: Down-regulation of osteopontin
expression by RNA interference affects cell proliferation and
chemotherapy sensitivity of breast cancer MDA-MB-231 cells. Mol Med
Rep. 5:373–376. 2012.PubMed/NCBI
|
